Carlsmed Inc (CARL)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Carlsmed Inc Stock (CARL) Company Profile

Carlsmed Inc

Healthcare (1111)

858-295-9290

1800 ASTON AVENUE, CARLSBAD

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CARL's Discussions on Twitter

Compare CARL vs VEEV, TEM, BTSG, HQY, WAY

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CARL Carlsmed Inc	10.68	292.72M	50.51M	-29.63M	0	-1.1459
VEEV Veeva Systems Inc	167.69	27.33B	3.20B	908.91M	1.39B	5.4168
TEM Tempus Ai Inc	54.42	10.12B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	45.80	8.89B	12.91B	104.80M	394.69M	0.8769
HQY Healthequity Inc	84.53	7.07B	1.31B	215.20M	408.32M	2.4627
WAY Waystar Holding Corp	25.32	4.73B	1.10B	112.09M	283.19M	0.6096

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-18	Eingeleitet	BTIG Research	Buy
2025-08-18	Eingeleitet	BofA Securities	Buy
2025-08-18	Eingeleitet	Goldman	Buy
2025-08-18	Eingeleitet	Piper Sandler	Overweight
2025-08-18	Eingeleitet	Truist	Buy

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Carlsmed Inc (CARL)

Carlsmed Inc Stock (CARL) Company Profile

Compare CARL vs VEEV, TEM, BTSG, HQY, WAY

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Carlsmed, Inc. (NASDAQ:CARL) Short Interest Up 23.4% in March - MarketBeat

Top Carlsmed (CARL) Competitors 2026 - MarketBeat

CARL Maintains Buy Rating -- Price Target Lowered to $18.00 by T - GuruFocus

Carlsmed (NASDAQ:CARL) Price Target Cut to $18.00 by Analysts at Truist Financial - MarketBeat

Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026 - The Manila Times

Carlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham Conf - Yahoo Finance

The Goldman Sachs Group Has Lowered Expectations for Carlsmed (NASDAQ:CARL) Stock Price - Defense World

Carlsmed (CARL) Analyst Rating: Goldman Sachs Lowers Price Targe - GuruFocus

Carlsmed (NASDAQ:CARL) Price Target Lowered to $17.00 at The Goldman Sachs Group - MarketBeat

CARL.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

CARL.O PE Ratio & Valuation, Is CARL.O Overvalued - Intellectia AI

CARL Technical Analysis & Stock Price Forecast - Intellectia AI

CARL News & Events - Intellectia AI

CARL.O Technical Analysis & Stock Price Forecast - Intellectia AI

Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference - Bitget

Carlsmed (NASDAQ:CARL) Upgraded at Zacks Research - Defense World

Carlsmed (NASDAQ:CARL) Upgraded by Zacks Research to Hold Rating - MarketBeat

Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Hold" from Analysts - MarketBeat

Carlsmed reports Q4, FY 2025 revenue above estimate - MSN

Carlsmed, Inc.: Fundamental Analysis and Financial Ratings | I82 | US14280C1053 - marketscreener.com

Carlsmed Poised for Positive Growth Trajectory - San Diego Business Journal

Carlsmed joins Russell 2000 Index following Q3 IPO - MSN

Head-To-Head Comparison: Carlsmed (CARL) vs. Its Rivals - Defense World

Comparing Carlsmed (CARL) & The Competition - Defense World

Head to Head Review: Carlsmed (CARL) and The Competition - Defense World

Carlsmed Earnings Call Highlights Rapid Growth, Rising Costs - TipRanks

Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish - MSN

Carlsmed (CARL) versus The Competition Head to Head Analysis - Defense World

Carlsmed unveils custom cervical plating tech - MSN

Carlsmed (CARL) vs. Its Peers Financial Survey - Defense World

Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference - Defense World

Contrasting Carlsmed (CARL) & Its Peers - Defense World

Carlsmed (CARL) vs. Its Competitors Head-To-Head Contrast - Defense World

Carlsmed (CARL) versus The Competition Financial Contrast - Defense World

CARLSMED CEO Michael Cordonnier Sells Shares - TradingView

Contrasting Carlsmed (CARL) & Its Rivals - Defense World

CARL: Personalized spine surgery platform posts 86% annual growth and expands into cervical market - TradingView

CARL: Personalized spine surgery platform drives rapid growth, clinical success, and strong reimbursement - TradingView

Carlsmed (CARL) vs. Its Rivals Critical Survey - Defense World

Brokerages Set Carlsmed, Inc. (NASDAQ:CARL) Target Price at $21.33 - Defense World

Carlsmed (CARL) versus Its Peers Financial Contrast - Defense World

Carlsmed (NASDAQ:CARL) Cut to “Strong Sell” at Zacks Research - Defense World

Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Wave Life Sciences (WVE) and Carlsmed, Inc. (CARL) - The Globe and Mail

Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Carlsmed (NASDAQ:CARL) Lowered to Strong Sell Rating by Zacks Research - MarketBeat

Head to Head Survey: Carlsmed (CARL) versus Its Competitors - Defense World

Carlsmed (CARL) Revenue Growth At 85.9% Tests Bearish Profitability Narratives - simplywall.st

Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer

Carlsmed Q4 Earnings Call Highlights - MarketBeat

Carlsmed, Inc. Reports Strong Q4 2025 Earnings and Growth Outlook - Intellectia AI

Carlsmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie CARL